Frontlight ResearchEarly access
CompletedPhase 3
The Effect of Mannitol Volume With Changes in Osmolarity in Traumatic Brain Injury
Key facts
- Who runs it
- Universitas Diponegoro
- Where
- Indonesia1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- Phase
- Phase 3
- People taking part
- 64 people enrolled
- Started
- 1 Nov 2023
- Ended
- 31 Jan 2024
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Mannitol
- Record updated
- 11 June 2026
Who can take part
- Age
- 18 years to 40 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Patients aged 18-40 years
- Glasgow Coma Scale (GCS) score indicating mild (14-13) or moderate (12-10)
Who cannot take part
- Renal impairment
- Multiple trauma with bleeding shock
- Diabetes mellitus
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This observational study is designed to research the effect of mannitol volume administration with changes in osmolarity in patients with traumatic brain injury to guide the safe use of mannitol in these patients.
The 3 groups in the trial
- Mannitol 1Existing treatment, for comparison
3×0.25 g/kg
Treatment: Mannitol
- Mannitol 2Existing treatment, for comparison
2×0.5 g/kg
Treatment: Mannitol
- Mannitol 3Existing treatment, for comparison
3×0.5 g/kg
Treatment: Mannitol
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- The Effect of Mannitol Volume Administration With Changes in Osmolarity in Traumatic Brain Injury: An Observational Study
- Record updated
- 11 June 2026